MetaADEDB 2.0 @ LMMD
Rivastigmine
(XSVMFMHYUFZWBK-NSHDSACASA-N)
Structure
SMILES
CCN(C(=O)Oc1cccc(c1)[C@@H](N(C)C)C)C
Type(s)
Approved; Investigational
ATC code(s)
N06DA03
Molecular Formula:
C14H22N2O2
Molecular Weight:
250.337
Log P:
2.7597
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
32.78
CAS Number(s):
123441-03-2; 415973-05-6
Synonym(s)
1.
Rivastigmine
2.
(S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate
3.
ENA 713
4.
ENA-713
5.
Exelon
6.
Rivastigmine Hydrogen Tartrate
7.
RivastigmineTartrate
8.
SDZ ENA 713
9.
713, ENA
10.
713, SDZ ENA
11.
ENA 713, SDZ
12.
ENA713
13.
Hydrogen Tartrate, Rivastigmine
14.
Tartrate, Rivastigmine Hydrogen
External Link(s)
MeSHD000068836
PubChem Compound77991
BindingDB11682
50342600
10620
ChEBI8874
CHEMBLCHEMBL636
DrugBankDB00989
DrugCentral2392
IUPHAR/BPS Guide to PHARMACOLOGY6602
KEGGcpd:C11766
dr:D03822
Therapeutic Target DatabaseD0WY5Q
ZINC4413
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1PneumoniaFAERS: 357
Canada Vigilance: 36
Canada Vigilance
SIDER
US FAERS
2Cerebrovascular accidentFAERS: 348
Canada Vigilance: 36
Canada Vigilance
SIDER
US FAERS
3VomitingFAERS: 330
Canada Vigilance: 60
Canada Vigilance
SIDER
US FAERS
4MalaiseFAERS: 327
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
5NauseaFAERS: 280
Canada Vigilance: 92
Canada Vigilance
OFFSIDES
SIDER
US FAERS
6Drug ineffectiveFAERS: 258
Canada Vigilance: 129
Canada Vigilance
US FAERS
7DizzinessFAERS: 203
Canada Vigilance: 37
Canada Vigilance
OFFSIDES
SIDER
US FAERS
8Product adhesion issueFAERS: 203
Canada Vigilance: 3
Canada Vigilance
US FAERS
9Memory impairmentFAERS: 201
Canada Vigilance: 11
Canada Vigilance
US FAERS
10Application site erythemaFAERS: 198
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
SIDER
US FAERS
11DementiaFAERS: 191
Canada Vigilance: 14
20865460CTD
SIDER
Canada Vigilance
US FAERS
12AstheniaFAERS: 169
Canada Vigilance: 28
Canada Vigilance
OFFSIDES
SIDER
US FAERS
13Weight decreasedFAERS: 164
Canada Vigilance: 48
Canada Vigilance
SIDER
US FAERS
14General physical health deteriorationFAERS: 149
Canada Vigilance: 12
Canada Vigilance
OFFSIDES
US FAERS
15AgitationFAERS: 146
Canada Vigilance: 23
Canada Vigilance
SIDER
US FAERS
16Application site pruritusFAERS: 138
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
17Urinary tract infectionFAERS: 127
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
18SyncopeFAERS: 121
Canada Vigilance: 24
20865460CTD
SIDER
Canada Vigilance
US FAERS
19Cardiac ArrestFAERS: 120
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
20Drug administration errorFAERS: 118OFFSIDES
US FAERS
21Feeling abnormalFAERS: 117SIDER
US FAERS
22TremorFAERS: 113
Canada Vigilance: 13
18294120CTD
SIDER
Canada Vigilance
US FAERS
23SomnolenceFAERS: 111
Canada Vigilance: 14
Canada Vigilance
SIDER
US FAERS
24Product use issueFAERS: 106US FAERS
25PruritusFAERS: 100
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
26Myocardial InfarctionFAERS: 93
Canada Vigilance: 17
Canada Vigilance
SIDER
US FAERS
27FatigueFAERS: 91
Canada Vigilance: 19
Canada Vigilance
SIDER
US FAERS
28AbasiaFAERS: 90OFFSIDES
US FAERS
29ErythemaFAERS: 87
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
30Wrong technique in product usage processFAERS: 86
Canada Vigilance: 1
Canada Vigilance
US FAERS
31DehydrationFAERS: 84
Canada Vigilance: 12
Canada Vigilance
OFFSIDES
SIDER
US FAERS
32InfectionFAERS: 83
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
33BradycardiaFAERS: 82
Canada Vigilance: 3
20865460CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
34DisorientationFAERS: 78
Canada Vigilance: 3
Canada Vigilance
US FAERS
35HypersensitivityFAERS: 78
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
36AnxietyFAERS: 77
Canada Vigilance: 16
Canada Vigilance
SIDER
US FAERS
37HeadacheFAERS: 77
Canada Vigilance: 16
Canada Vigilance
SIDER
US FAERS
38DeliriumFAERS: 71
Canada Vigilance: 8
11199939CTD
SIDER
Canada Vigilance
US FAERS
39Wrong technique in drug usage processFAERS: 70US FAERS
40Diabetes MellitusFAERS: 68
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
41AmnesiaFAERS: 67
Canada Vigilance: 3
19345205CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
42Application site rashFAERS: 67OFFSIDES
SIDER
US FAERS
43Abdominal PainFAERS: 64
Canada Vigilance: 22
Canada Vigilance
SIDER
US FAERS
44Respiratory FailureFAERS: 64
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
45PainFAERS: 60
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
46Incorrect dose administeredFAERS: 57
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
47AphasiaFAERS: 52
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
48Application site hypersensitivityFAERS: 52OFFSIDES
SIDER
US FAERS
49NervousnessFAERS: 50
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
50Respiratory arrestFAERS: 49US FAERS
51RestlessnessFAERS: 48
Canada Vigilance: 4
Canada Vigilance
US FAERS
52Skin irritationFAERS: 47
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
53Disease ProgressionFAERS: 46
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
54Application site irritationFAERS: 45OFFSIDES
SIDER
US FAERS
55OverdoseFAERS: 45
Canada Vigilance: 2
Canada Vigilance
US FAERS
56SepsisFAERS: 45
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
57HypotensionFAERS: 44
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
58Inappropriate schedule of drug administrationFAERS: 42US FAERS
59FractureFAERS: 41
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
60InfarctionFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
61Cerebral InfarctionFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
62Urinary IncontinenceFAERS: 38
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
63HypophagiaFAERS: 35OFFSIDES
US FAERS
64DeafnessFAERS: 34SIDER
US FAERS
65Abdominal discomfortFAERS: 32
Canada Vigilance: 10
Canada Vigilance
US FAERS
66Application site reactionFAERS: 32OFFSIDES
US FAERS
67ChokingFAERS: 32
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
68Chest PainFAERS: 30
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
69Concomitant disease aggravatedFAERS: 30OFFSIDES
US FAERS
70Drug prescribing errorFAERS: 29US FAERS
71InfluenzaFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
72Product use in unapproved indicationFAERS: 29US FAERS
73Senile dementiaFAERS: 29OFFSIDES
US FAERS
74PallorFAERS: 28
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
75Septic ShockFAERS: 28US FAERS
76Incorrect drug administration durationFAERS: 27US FAERS
77ThrombosisFAERS: 27
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
78UrticariaFAERS: 27
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
79Visual ImpairmentFAERS: 27
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
80Application site swellingFAERS: 26OFFSIDES
US FAERS
81Atrial FibrillationFAERS: 26
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
82CryingFAERS: 26
Canada Vigilance: 3
Canada Vigilance
US FAERS
83EpilepsyFAERS: 26SIDER
US FAERS
84Skin reactionFAERS: 26
Canada Vigilance: 2
Canada Vigilance
US FAERS
85Depressed Level of ConsciousnessFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
86HemiplegiaFAERS: 25
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
87Musculoskeletal stiffnessFAERS: 25
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
88ConstipationFAERS: 24
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
89HypokinesiaFAERS: 24
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
90LethargyFAERS: 24
Canada Vigilance: 4
Canada Vigilance
US FAERS
91DysenteryFAERS: 23US FAERS
92PalpitationsFAERS: 23
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
93TachycardiaFAERS: 23
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
94Altered state of consciousnessFAERS: 22US FAERS
95Application site vesiclesFAERS: 22OFFSIDES
US FAERS
96Depressed moodFAERS: 22
Canada Vigilance: 2
Canada Vigilance
US FAERS
97DysarthriaFAERS: 22
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
98Medication ErrorFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
99nervous system disorderFAERS: 22SIDER
US FAERS
100AngerFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
101AphagiaFAERS: 21US FAERS
102Application site painFAERS: 21OFFSIDES
SIDER
US FAERS
103BronchitisFAERS: 21
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
104MarasmusFAERS: 21US FAERS
105NasopharyngitisFAERS: 21
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
106Urinary RetentionFAERS: 21
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
107MalnutritionFAERS: 20
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
108Unresponsive to stimuliFAERS: 20OFFSIDES
US FAERS
109VertigoFAERS: 20SIDER
US FAERS
110Concomitant disease progressionFAERS: 19OFFSIDES
US FAERS
111Intestinal ObstructionFAERS: 19
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
112Mental impairmentFAERS: 19
Canada Vigilance: 12
Canada Vigilance
US FAERS
113Angina PectorisFAERS: 18
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
114AsthmaFAERS: 18US FAERS
115ApathyFAERS: 17
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
116Apparent deathFAERS: 17US FAERS
117Blood creatinine increasedFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
118PancreatitisFAERS: 17
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
119ParanoiaFAERS: 17
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
SIDER
US FAERS
120Pulmonary EmbolismFAERS: 17
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
121Blood glucose increasedFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
122CataractFAERS: 16
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
123DysuriaFAERS: 16SIDER
US FAERS
124GastritisFAERS: 16
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
125SwellingFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
126AnorexiaFAERS: 15OFFSIDES
SIDER
US FAERS
127BlindnessFAERS: 15US FAERS
128Blood cholinesterase decreasedFAERS: 15US FAERS
129Cerebral ThrombosisFAERS: 15US FAERS
130Accidental exposure to productFAERS: 14US FAERS
131Acute myocardial infarctionFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
132Back PainFAERS: 14
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
133BedriddenFAERS: 14OFFSIDES
US FAERS
134Lack of application site rotationFAERS: 14US FAERS
135No adverse eventFAERS: 14US FAERS
136RetchingFAERS: 14US FAERS
137ArthralgiaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
138HydrocephalusFAERS: 13US FAERS
139HypersomniaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
140Pancreatic carcinomaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
141Product quality issueFAERS: 13US FAERS
142Product substitution issueFAERS: 13
Canada Vigilance: 3
Canada Vigilance
US FAERS
143ShockFAERS: 13SIDER
US FAERS
144Terminal stateFAERS: 13OFFSIDES
US FAERS
145Activities of daily living impairedFAERS: 12OFFSIDES
US FAERS
146Blood sodium decreasedFAERS: 12US FAERS
147CholelithiasisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
148Electrolyte imbalanceFAERS: 12US FAERS
149Therapy cessationFAERS: 12OFFSIDES
US FAERS
150Toxicity to various agentsFAERS: 12US FAERS
151Accidental exposureFAERS: 11OFFSIDES
US FAERS
152Accidental overdoseFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
153BronchopneumoniaFAERS: 11OFFSIDES
US FAERS
154Drug administered at inappropriate siteFAERS: 11US FAERS
155DyspepsiaFAERS: 11
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
156Electrocardiogram abnormalFAERS: 11SIDER
US FAERS
157Gait inabilityFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
158Hypertensive crisisFAERS: 11US FAERS
159Muscle RigidityFAERS: 1118294120CTD
SIDER
US FAERS
160Psychiatric symptomFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
161Alanine Aminotransferase IncreasedFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
162Blood pressure fluctuationFAERS: 10
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
163Chest discomfortFAERS: 10US FAERS
164ChillsFAERS: 10
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
165CyanosisFAERS: 10US FAERS
166GastroenteritisFAERS: 10
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
167IncontinenceFAERS: 10
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
168LabyrinthitisFAERS: 10US FAERS
169MyoclonusFAERS: 10SIDER
US FAERS
170OsteoporosisFAERS: 10SIDER
US FAERS
171Personality ChangeFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
172ArthritisFAERS: 9SIDER
US FAERS
173Atrioventricular BlockFAERS: 9
Canada Vigilance: 1
18499878CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
174Blood potassium decreasedFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
175Blood urea increasedFAERS: 9OFFSIDES
US FAERS
176Cold sweatFAERS: 9OFFSIDES
SIDER
US FAERS
177DysgraphiaFAERS: 9OFFSIDES
US FAERS
178Feeling ColdFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
179General physical condition abnormalFAERS: 9US FAERS
180HerniaFAERS: 9SIDER
US FAERS
181IleusFAERS: 9US FAERS
182Incorrect route of drug administrationFAERS: 9US FAERS
183Macular degenerationFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
184MetastasisFAERS: 9US FAERS
185Musculoskeletal PainFAERS: 9US FAERS
186Post procedural complicationFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
187Sudden deathFAERS: 9US FAERS
188jaundiceFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
189AgnosiaFAERS: 8OFFSIDES
US FAERS
190Application site burnFAERS: 8SIDER
US FAERS
191Aspartate Aminotransferase IncreasedFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
192CatatoniaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
193Coronary Artery DiseaseFAERS: 8SIDER
US FAERS
194DiverticulitisFAERS: 8
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
195Drug DependenceFAERS: 8US FAERS
196DysphoniaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
197Gastrointestinal carcinomaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
198Gastrointestinal infectionFAERS: 8US FAERS
199Head discomfortFAERS: 8US FAERS
200HypoxiaFAERS: 8US FAERS
201Increased bronchial secretionFAERS: 8US FAERS
202Neck PainFAERS: 8US FAERS
203NephrolithiasisFAERS: 8SIDER
US FAERS
204PresyncopeFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
205Product administration interruptedFAERS: 8US FAERS
206Skin lesionFAERS: 8US FAERS
207AlopeciaFAERS: 7SIDER
US FAERS
208AneurysmFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
209Bipolar DisorderFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
210CachexiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
211CellulitisFAERS: 7SIDER
US FAERS
212EczemaFAERS: 7SIDER
US FAERS
213EmbolismFAERS: 7OFFSIDES
US FAERS
214EpistaxisFAERS: 7SIDER
US FAERS
215Gastrointestinal motility disorderFAERS: 7US FAERS
216Gastrointestinal sounds abnormalFAERS: 7OFFSIDES
US FAERS
217HepatitisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
218IncoherentFAERS: 7OFFSIDES
US FAERS
219InflammationFAERS: 7SIDER
US FAERS
220Limb injuryFAERS: 7US FAERS
221MyalgiaFAERS: 7SIDER
US FAERS
222PoisoningFAERS: 7US FAERS
223ScreamingFAERS: 7OFFSIDES
US FAERS
224Sinus bradycardiaFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
225Spinal column injuryFAERS: 7US FAERS
226Stevens-Johnson SyndromeFAERS: 725811541CTD
SIDER
US FAERS
227StressFAERS: 7US FAERS
228Suicide attemptFAERS: 7SIDER
US FAERS
229ThrombocytopeniaFAERS: 7
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
230TuberculosisFAERS: 7US FAERS
231UlcerFAERS: 7US FAERS
232AkinesiaFAERS: 6OFFSIDES
US FAERS
233Benign Prostatic HyperplasiaFAERS: 6OFFSIDES
SIDER
US FAERS
234Blood alkaline phosphatase increasedFAERS: 6SIDER
US FAERS
235Blood glucose decreasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
236Blood urine presentFAERS: 6US FAERS
237CardiomegalyFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
238CystitisFAERS: 6
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
239DermatitisFAERS: 6SIDER
US FAERS
240Drug dispensing errorFAERS: 6US FAERS
241Drug withdrawal syndromeFAERS: 6US FAERS
242Emotional disorderFAERS: 6US FAERS
243ErysipelasFAERS: 6US FAERS
244GlaucomaFAERS: 6SIDER
US FAERS
245HypothyroidismFAERS: 6SIDER
US FAERS
246Inappropriate schedule of product administrationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
247Joint injuryFAERS: 6US FAERS
248LeukocytosisFAERS: 6
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
249Limb discomfortFAERS: 6US FAERS
250Lower respiratory tract infectionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
251Mental status changesFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
252Middle insomniaFAERS: 6US FAERS
253PleurothotonusFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
254Respiratory distressFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
255Therapeutic response unexpectedFAERS: 6US FAERS
256Tooth LossFAERS: 6US FAERS
257WheezingFAERS: 6US FAERS
258Acute psychosisFAERS: 5US FAERS
259AgeusiaFAERS: 5SIDER
US FAERS
260Ankle FractureFAERS: 5US FAERS
261Application site erosionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
262Application site exfoliationFAERS: 5OFFSIDES
US FAERS
263ArteriosclerosisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
264Behavioural and psychiatric symptoms of dementiaFAERS: 5US FAERS
265Blood creatine phosphokinase increasedFAERS: 5SIDER
US FAERS
266Burning sensationFAERS: 5US FAERS
267Cerebral atrophyFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
268Completed SuicideFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
269Diabetes mellitus inadequate controlFAERS: 5US FAERS
270Diet refusalFAERS: 5US FAERS
271DiscomfortFAERS: 5SIDER
US FAERS
272DroolingFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
273Drug dose omissionFAERS: 5US FAERS
274Drug toxicityFAERS: 5US FAERS
275EcchymosisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
276EscharFAERS: 5OFFSIDES
US FAERS
277ExcoriationFAERS: 5OFFSIDES
US FAERS
278FlushingFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
279Frontotemporal dementiaFAERS: 5US FAERS
280Gamma-Glutamyltransferase IncreasedFAERS: 5US FAERS
281HyporeflexiaFAERS: 5SIDER
US FAERS
282LacerationFAERS: 5US FAERS
283Neuroleptic Malignant SyndromeFAERS: 518294120CTD
US FAERS
284Poor quality sleepFAERS: 5US FAERS
285PurpuraFAERS: 5SIDER
US FAERS
286PyelonephritisFAERS: 5US FAERS
287Respiratory DepressionFAERS: 5US FAERS
288Sick Sinus SyndromeFAERS: 5OFFSIDES
SIDER
US FAERS
289Status EpilepticusFAERS: 5US FAERS
290UnderweightFAERS: 5US FAERS
291Aortic AneurysmFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
292Application site discomfortFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
293Application site massFAERS: 4US FAERS
294Application site urticariaFAERS: 4US FAERS
295AscitesFAERS: 4US FAERS
296Bladder NeoplasmFAERS: 4US FAERS
297Blood cholesterol increasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
298Blood lactate dehydrogenase increasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
299Central nervous system lesionFAERS: 4US FAERS
300Cerebral disorderFAERS: 4US FAERS
301Delusional disorder, unspecified typeFAERS: 4OFFSIDES
US FAERS
302DiverticulumFAERS: 4US FAERS
303Drug level increasedFAERS: 4US FAERS
304Dry skinFAERS: 4SIDER
US FAERS
305Duodenal UlcerFAERS: 4OFFSIDES
SIDER
US FAERS
306DysphemiaFAERS: 4US FAERS
307DystoniaFAERS: 4
Canada Vigilance: 1
18029952CTD
Canada Vigilance
US FAERS
308Erythema MultiformeFAERS: 4SIDER
US FAERS
309Expired product administeredFAERS: 4US FAERS
310Failure to ThriveFAERS: 4OFFSIDES
US FAERS
311FlatulenceFAERS: 4
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
312Gastric ulcerFAERS: 4SIDER
US FAERS
313HemiparesisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
314Hip surgeryFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
315LymphomaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
316Malignant neoplasm progressionFAERS: 4US FAERS
317Mechanical ventilationFAERS: 4US FAERS
318Metastatic NeoplasmFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
319MoaningFAERS: 4US FAERS
320Obsessive-Compulsive DisorderFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
321Paroxysmal arrhythmiaFAERS: 4OFFSIDES
US FAERS
322PemphigusFAERS: 4US FAERS
323Peptic UlcerFAERS: 4SIDER
US FAERS
324Product measured potency issueFAERS: 4US FAERS
325Pulmonary sepsisFAERS: 4OFFSIDES
US FAERS
326Rash erythematousFAERS: 4SIDER
US FAERS
327SchizophreniaFAERS: 4US FAERS
328Sinus TachycardiaFAERS: 4US FAERS
329SluggishnessFAERS: 4US FAERS
330SneezingFAERS: 4US FAERS
331StubbornnessFAERS: 4US FAERS
332Transaminases increasedFAERS: 4US FAERS
333Trigeminal NeuralgiaFAERS: 4US FAERS
334Venous occlusionFAERS: 4OFFSIDES
US FAERS
335Acute prerenal failureFAERS: 3US FAERS
336Acute respiratory failureFAERS: 3US FAERS
337AngioedemaFAERS: 3US FAERS
338AphoniaFAERS: 3US FAERS
339Apparent life threatening eventFAERS: 3OFFSIDES
US FAERS
340Application site inflammationFAERS: 3OFFSIDES
US FAERS
341ArthropathyFAERS: 3
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
342Biliary dilatationFAERS: 3US FAERS
343Blood albumin decreasedFAERS: 3US FAERS
344Bone painFAERS: 3SIDER
US FAERS
345Brain HypoxiaFAERS: 3OFFSIDES
US FAERS
346BronchospasmFAERS: 3SIDER
US FAERS
347Cognitive deteriorationFAERS: 3OFFSIDES
US FAERS
348ColitisFAERS: 3SIDER
US FAERS
349Deep Vein ThrombosisFAERS: 3US FAERS
350Dengue FeverFAERS: 3US FAERS
351Diastolic hypertensionFAERS: 3US FAERS
352DrowningFAERS: 3US FAERS
353Drug ineffective for unapproved indicationFAERS: 3US FAERS
354Drug resistanceFAERS: 3US FAERS
355Electroencephalogram abnormalFAERS: 3US FAERS
356EnuresisFAERS: 3OFFSIDES
US FAERS
357Escherichia urinary tract infectionFAERS: 3US FAERS
358Facial paralysisFAERS: 3US FAERS
359Food aversionFAERS: 3US FAERS
360Frustration tolerance decreasedFAERS: 3US FAERS
361GangreneFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
362Gastrointestinal PainFAERS: 3SIDER
US FAERS
363Gaze palsyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
364HyperkinesiaFAERS: 3SIDER
US FAERS
365HypervigilanceFAERS: 3OFFSIDES
US FAERS
366Hypotonic-hyporesponsive episodeFAERS: 3US FAERS
367Infrequent bowel movementsFAERS: 3US FAERS
368Intracranial AneurysmFAERS: 3US FAERS
369Joint swellingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
370Lipase increasedFAERS: 3SIDER
US FAERS
371MYELODYSPLASTIC SYNDROMEFAERS: 3US FAERS
372MonoplegiaFAERS: 3US FAERS
373Mood swingsFAERS: 3SIDER
US FAERS
374Multi-organ disorderFAERS: 3US FAERS
375Multiple SclerosisFAERS: 3US FAERS
376Musculoskeletal discomfortFAERS: 3SIDER
US FAERS
377NegativismFAERS: 3US FAERS
378Nonspecific reactionFAERS: 3US FAERS
379ObesityFAERS: 3US FAERS
380OliguriaFAERS: 3SIDER
US FAERS
381Panic DisorderFAERS: 3OFFSIDES
US FAERS
382ParaplegiaFAERS: 3US FAERS
383Peripheral swellingFAERS: 3US FAERS
384PharyngitisFAERS: 3SIDER
US FAERS
385Procedural complicationFAERS: 3US FAERS
386Product packaging issueFAERS: 3US FAERS
387Productive CoughFAERS: 3OFFSIDES
US FAERS
388Pulmonary FibrosisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
389RalesFAERS: 3OFFSIDES
US FAERS
390Saliva alteredFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
391SciaticaFAERS: 3US FAERS
392Skeletal injuryFAERS: 3OFFSIDES
US FAERS
393Skin UlcerFAERS: 3SIDER
US FAERS
394Skin hypertrophyFAERS: 3SIDER
US FAERS
395SomnambulismFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
396StuporFAERS: 3US FAERS
397ThirstFAERS: 3SIDER
US FAERS
398Urinary tract obstructionFAERS: 3US FAERS
399VIIth nerve paralysisFAERS: 3US FAERS
400Accidental drug intake by childFAERS: 2US FAERS
401AcneFAERS: 2US FAERS
402Acute kidney injuryFAERS: 2US FAERS
403AdenocarcinomaFAERS: 2SIDER
US FAERS
404AgranulocytosisFAERS: 2US FAERS
405Animal biteFAERS: 2US FAERS
406AnosmiaFAERS: 2US FAERS
407Anticholinergic SyndromeFAERS: 2US FAERS
408AnuriaFAERS: 2US FAERS
409Apallic syndromeFAERS: 2US FAERS
410Application site dischargeFAERS: 2US FAERS
411Application site drynessFAERS: 2US FAERS
412Application site scabFAERS: 2US FAERS
413Arteriosclerosis ObliteransFAERS: 2US FAERS
414AsphyxiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
415BelligerenceFAERS: 2US FAERS
416Blood glucose abnormalFAERS: 2US FAERS
417Blood potassium increasedFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
418Blood pressure inadequately controlledFAERS: 2US FAERS
419Blood thyroid stimulating hormone decreasedFAERS: 2US FAERS
420Bone fissureFAERS: 2US FAERS
421BradyphreniaFAERS: 2US FAERS
422Brain DeathFAERS: 2US FAERS
423Bronchial ObstructionFAERS: 2US FAERS
424Cardio-respiratory distressFAERS: 2US FAERS
425Cell marker increasedFAERS: 2US FAERS
426Cerebral cystFAERS: 2US FAERS
427Cerebral ventricle dilatationFAERS: 2US FAERS
428Choking sensationFAERS: 2US FAERS
429CholecystitisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
430CholestasisFAERS: 219888250CTD
US FAERS
431ChromaturiaFAERS: 2US FAERS
432Colonic Pseudo-ObstructionFAERS: 2US FAERS
433Compression fractureFAERS: 2US FAERS
434Conversion disorderFAERS: 2US FAERS
435Creatinine renal clearance decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
436CystFAERS: 2US FAERS
437Cytolytic hepatitisFAERS: 2US FAERS
438Decreased immune responsivenessFAERS: 2US FAERS
439Device leakageFAERS: 2US FAERS
440DiplegiaFAERS: 2US FAERS
441DiplopiaFAERS: 2SIDER
US FAERS
442Drug titration errorFAERS: 2US FAERS
443DysgeusiaFAERS: 2SIDER
US FAERS
444DysphasiaFAERS: 2OFFSIDES
US FAERS
445Eating disorder symptomFAERS: 2OFFSIDES
US FAERS
446Ejection Fraction DecreasedFAERS: 2OFFSIDES
US FAERS
447Electrocardiogram changeFAERS: 2OFFSIDES
US FAERS
448EnterocolitisFAERS: 2US FAERS
449EructationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
450Euphoric moodFAERS: 2US FAERS
451Extremity contractureFAERS: 2US FAERS
452Eye irritationFAERS: 2US FAERS
453Feeling jitteryFAERS: 2US FAERS
454Food PoisoningFAERS: 2US FAERS
455Freezing phenomenonFAERS: 2OFFSIDES
SIDER
US FAERS
456GastrectomyFAERS: 2OFFSIDES
US FAERS
457Gastric infectionFAERS: 2US FAERS
458Gastroenteritis norovirusFAERS: 2US FAERS
459Gastrointestinal angiodysplasia haemorrhagicFAERS: 2US FAERS
460Gastrointestinal hypomotilityFAERS: 2OFFSIDES
US FAERS
461Gastrointestinal ulcerFAERS: 2OFFSIDES
US FAERS
462GoutFAERS: 2SIDER
US FAERS
463Heat illnessFAERS: 2US FAERS
464Hepatic EncephalopathyFAERS: 2US FAERS
465Hepatic calcificationFAERS: 2US FAERS
466HungerFAERS: 2US FAERS
467HyperventilationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
468Hyporesponsive to stimuliFAERS: 2US FAERS
469Impaired reasoningFAERS: 2US FAERS
470Impaired self-careFAERS: 2US FAERS
471Incorrect drug administration rateFAERS: 2US FAERS
472Incorrect drug dosage form administeredFAERS: 2US FAERS
473Incorrect product administration durationFAERS: 2US FAERS
474Increased upper airway secretionFAERS: 2US FAERS
475Intestinal PerforationFAERS: 2US FAERS
476Intestinal resectionFAERS: 2OFFSIDES
US FAERS
477Joint stiffnessFAERS: 2US FAERS
478Lack of spontaneous speechFAERS: 2OFFSIDES
US FAERS
479Lip swellingFAERS: 2US FAERS
480Livedo ReticularisFAERS: 2US FAERS
481Lung consolidationFAERS: 2OFFSIDES
US FAERS
482Mastication disorderFAERS: 2US FAERS
483MeaslesFAERS: 2US FAERS
484Medical device discomfortFAERS: 2US FAERS
485Micturition frequency decreasedFAERS: 2US FAERS
486Multiple System AtrophyFAERS: 2US FAERS
487Musculoskeletal chest painFAERS: 2US FAERS
488MydriasisFAERS: 2US FAERS
489Myoclonic EpilepsyFAERS: 2US FAERS
490Night sweatsFAERS: 2US FAERS
491NoduleFAERS: 2US FAERS
492Open woundFAERS: 2US FAERS
493Oropharyngeal discomfortFAERS: 2US FAERS
494Osteitis DeformansFAERS: 2US FAERS
495Oxygen supplementationFAERS: 2OFFSIDES
US FAERS
496Pain of skinFAERS: 2US FAERS
497Pancreatic CystFAERS: 2US FAERS
498PanniculitisFAERS: 2US FAERS
499ParesisFAERS: 2SIDER
US FAERS
500Parkinsonian rest tremorFAERS: 2US FAERS
501Pathological fractureFAERS: 2
Canada Vigilance: 30
Canada Vigilance
US FAERS
502Perforated ulcerFAERS: 2US FAERS
503Performance status decreasedFAERS: 2US FAERS
504Pericardial effusionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
505Periorbital contusionFAERS: 2US FAERS
506PeritonitisFAERS: 2SIDER
US FAERS
507PetechiaeFAERS: 2US FAERS
508PhlebitisFAERS: 2SIDER
US FAERS
509PolyneuropathyFAERS: 2US FAERS
510Poor peripheral circulationFAERS: 2US FAERS
511PoriomaniaFAERS: 2US FAERS
512Post procedural infectionFAERS: 2US FAERS
513Post procedural pulmonary embolismFAERS: 2OFFSIDES
US FAERS
514Prescribed underdoseFAERS: 2US FAERS
515Product administration errorFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
516Pulmonary congestionFAERS: 2US FAERS
517Pulmonary thrombosisFAERS: 2US FAERS
518Respiratory tract congestionFAERS: 2US FAERS
519Retinal DetachmentFAERS: 2US FAERS
520ScabFAERS: 2OFFSIDES
US FAERS
521SinusitisFAERS: 2SIDER
US FAERS
522Sleep TalkingFAERS: 2US FAERS
523Spinal column stenosisFAERS: 2US FAERS
524SpondylolisthesisFAERS: 2US FAERS
525Subcutaneous AbscessFAERS: 2US FAERS
526Suture insertionFAERS: 2OFFSIDES
US FAERS
527Tardive DyskinesiaFAERS: 2US FAERS
528Therapeutic response changedFAERS: 2US FAERS
529ThrombophlebitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
530TinnitusFAERS: 2SIDER
US FAERS
531Troponin I increasedFAERS: 2US FAERS
532Umbilical herniaFAERS: 2US FAERS
533Unevaluable eventFAERS: 2US FAERS
534Urinary Tract PainFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
535Vascular calcificationFAERS: 2OFFSIDES
US FAERS
536Ventricular FibrillationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
537Wound ComplicationFAERS: 2US FAERS
538effusionFAERS: 2US FAERS
539muscle injuryFAERS: 2US FAERS
540ovarian neoplasmFAERS: 2US FAERS
541Abdominal massFAERS: 1US FAERS
542Abdominal strangulated herniaFAERS: 1US FAERS
543Abdominal tendernessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
544AbscessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
545AcarodermatitisFAERS: 1US FAERS
546Accessory cardiac pathwayFAERS: 1US FAERS
547Accidental exposure to product by childFAERS: 1US FAERS
548Accidental underdoseFAERS: 1US FAERS
549Acquired Immunodeficiency SyndromeFAERS: 1US FAERS
550Actinic keratosisFAERS: 1US FAERS
551Administration site erythemaFAERS: 1US FAERS
552Administration site pruritusFAERS: 1US FAERS
553Administration site reactionFAERS: 1US FAERS
554Adverse eventFAERS: 1US FAERS
555AmaurosisFAERS: 1US FAERS
556Ammonia increasedFAERS: 1US FAERS
557Amylase increasedFAERS: 1SIDER
US FAERS
558Amyotrophic Lateral SclerosisFAERS: 1US FAERS
559Anal FistulaFAERS: 1US FAERS
560Anal abscessFAERS: 1US FAERS
561Anal infectionFAERS: 1US FAERS
562Anaphylactic shockFAERS: 1US FAERS
563Anaphylactoid ReactionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
564Antiphospholipid SyndromeFAERS: 1US FAERS
565Aortic RuptureFAERS: 1US FAERS
566Aortic aneurysm repairFAERS: 1US FAERS
567AppendicitisFAERS: 1US FAERS
568Application site acneFAERS: 1US FAERS
569Application site infectionFAERS: 1US FAERS
570Application site injuryFAERS: 1US FAERS
571Application site lacerationFAERS: 1US FAERS
572Application site papulesFAERS: 1US FAERS
573Application site perspirationFAERS: 1US FAERS
574Application site scarFAERS: 1OFFSIDES
US FAERS
575Application site woundFAERS: 1US FAERS
576Arthropod biteFAERS: 1US FAERS
577AtaxiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
578AtelectasisFAERS: 1US FAERS
579AtopyFAERS: 1US FAERS
580Atrial ruptureFAERS: 1US FAERS
581Atrioventricular conduction time shortenedFAERS: 1US FAERS
582Autonomic nervous system imbalanceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
583Back disorderFAERS: 1US FAERS
584Basal cell carcinomaFAERS: 1SIDER
US FAERS
585Basophil percentage decreasedFAERS: 1US FAERS
586Bile output decreasedFAERS: 1US FAERS
587Biliary ColicFAERS: 1US FAERS
588Bladder dysfunctionFAERS: 1US FAERS
589BlepharospasmFAERS: 1SIDER
US FAERS
590Blister ruptureFAERS: 1US FAERS
591Blood albumin increasedFAERS: 1US FAERS
592Blood amylase increasedFAERS: 1OFFSIDES
SIDER
US FAERS
593Blood bilirubin decreasedFAERS: 1US FAERS
594Blood count abnormalFAERS: 1US FAERS
595Blood creatine increasedFAERS: 1OFFSIDES
US FAERS
596Blood creatinine abnormalFAERS: 1US FAERS
597Blood electrolytes abnormalFAERS: 1US FAERS
598Blood fibrinogen increasedFAERS: 1US FAERS
599Blood glucose fluctuationFAERS: 1US FAERS
600Blood iron decreasedFAERS: 1US FAERS
601Blood pH decreasedFAERS: 1US FAERS
602Blood potassium abnormalFAERS: 1US FAERS
603Blood sodium abnormalFAERS: 1US FAERS
604Blood sodium increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
605Body surface area decreasedFAERS: 1US FAERS
606Body temperature fluctuationFAERS: 1US FAERS
607Bone density decreasedFAERS: 1US FAERS
608Bone fragmentationFAERS: 1US FAERS
609Bone lesionFAERS: 1US FAERS
610Bone marrow granulomaFAERS: 1US FAERS
611Bowel movement irregularityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
612Brain scan abnormalFAERS: 1US FAERS
613Breast cancer recurrentFAERS: 1US FAERS
614BronchopneumopathyFAERS: 1US FAERS
615BunionFAERS: 1US FAERS
616BursitisFAERS: 1SIDER
US FAERS
617CamptocormiaFAERS: 1US FAERS
618Cardiac HypertrophyFAERS: 1US FAERS
619Cardiac dysfunctionFAERS: 1US FAERS
620Cardiac electrophysiologic study abnormalFAERS: 1US FAERS
621Cardiac monitoringFAERS: 1US FAERS
622Cardiovascular insufficiencyFAERS: 1OFFSIDES
US FAERS
623Cell DeathFAERS: 1US FAERS
624Cerebellar AtaxiaFAERS: 1US FAERS
625Cerebral artery occlusionFAERS: 1OFFSIDES
US FAERS
626Cerebral artery stenosisFAERS: 1US FAERS
627Cervicobrachial syndromeFAERS: 1US FAERS
628Cervix carcinomaFAERS: 1US FAERS
629Chemical injuryFAERS: 1US FAERS
630Cholecystitis infectiveFAERS: 1US FAERS
631Chronic respiratory failureFAERS: 1US FAERS
632Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
633Clostridium difficile colitisFAERS: 1US FAERS
634Cluster HeadacheFAERS: 1US FAERS
635Complication associated with deviceFAERS: 1US FAERS
636Congenital renal disorderFAERS: 1US FAERS
637Corneal graft rejectionFAERS: 1US FAERS
638Coronary angioplastyFAERS: 1OFFSIDES
US FAERS
639Coronary artery insufficiencyFAERS: 1US FAERS
640Cutis LaxaFAERS: 1US FAERS
641CystoscopyFAERS: 1US FAERS
642Delusional disorder, persecutory typeFAERS: 1US FAERS
643Dental cariesFAERS: 1SIDER
US FAERS
644DependenceFAERS: 1US FAERS
645Device occlusionFAERS: 1US FAERS
646Device related infectionFAERS: 1US FAERS
647Device use errorFAERS: 1US FAERS
648Diabetic FootFAERS: 1US FAERS
649Diabetic KetoacidosisFAERS: 1US FAERS
650Diabetic ulcerFAERS: 1US FAERS
651Diaphragmatic HerniaFAERS: 1US FAERS
652DisabilityFAERS: 1US FAERS
653Disease complicationFAERS: 1US FAERS
654Disease recurrenceFAERS: 1US FAERS
655Disseminated Intravascular CoagulationFAERS: 1US FAERS
656Drug ToleranceFAERS: 1US FAERS
657Drug abuseFAERS: 1US FAERS
658Drug effect incompleteFAERS: 1US FAERS
659Drug label confusionFAERS: 1US FAERS
660Drug level fluctuatingFAERS: 1US FAERS
661DuodenitisFAERS: 1OFFSIDES
US FAERS
662Ear discomfortFAERS: 1US FAERS
663Elevated moodFAERS: 1US FAERS
664Emotional distressFAERS: 1US FAERS
665EmpyemaFAERS: 1US FAERS
666EncephalitisFAERS: 1US FAERS
667Endometrial disorderFAERS: 1US FAERS
668Endoscopy abnormalFAERS: 1OFFSIDES
US FAERS
669Enteral NutritionFAERS: 1US FAERS
670Enterocolitis bacterialFAERS: 1US FAERS
671Expired drug administeredFAERS: 1OFFSIDES
US FAERS
672Extra dose administeredFAERS: 1US FAERS
673Eyeball ruptureFAERS: 1US FAERS
674Feelings of worthlessnessFAERS: 1US FAERS
675Fibrin D dimer increasedFAERS: 1US FAERS
676FibromyalgiaFAERS: 1US FAERS
677Fluid overloadFAERS: 1US FAERS
678Food cravingFAERS: 1US FAERS
679FormicationFAERS: 1US FAERS
680FrustrationFAERS: 1US FAERS
681Gait ApraxiaFAERS: 1US FAERS
682Gait deviationFAERS: 1US FAERS
683Gallbladder hypofunctionFAERS: 1US FAERS
684Gastric FistulaFAERS: 1US FAERS
685Gastric LavageFAERS: 1OFFSIDES
US FAERS
686Gastric pH decreasedFAERS: 1US FAERS
687GastroduodenitisFAERS: 1US FAERS
688Gastrointestinal bacterial infectionFAERS: 1US FAERS
689Gastrointestinal inflammationFAERS: 1US FAERS
690Gastrointestinal perforationFAERS: 1US FAERS
691Gastrointestinal viral infectionFAERS: 1US FAERS
692GastrostomyFAERS: 1OFFSIDES
US FAERS
693General physical conditionFAERS: 1OFFSIDES
US FAERS
694Glasgow coma scale abnormalFAERS: 1US FAERS
695GlioblastomaFAERS: 1US FAERS
696Grip strength decreasedFAERS: 1US FAERS
697HaematinuriaFAERS: 1US FAERS
698Hallucinations, mixedFAERS: 1US FAERS
699Heat StrokeFAERS: 1US FAERS
700HemicephalalgiaFAERS: 1US FAERS
701Hepatic InfectionFAERS: 1US FAERS
702HepatomegalyFAERS: 1US FAERS
703HepatotoxicityFAERS: 1US FAERS
704Hernia obstructiveFAERS: 1US FAERS
705Herpes zoster infection neurologicalFAERS: 1US FAERS
706HyperlipasaemiaFAERS: 1US FAERS
707HyperplasiaFAERS: 1US FAERS
708HyperpyrexiaFAERS: 1SIDER
US FAERS
709HyperreflexiaFAERS: 1SIDER
US FAERS
710HypersplenismFAERS: 1US FAERS
711HyperthyroidismFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
712HypoventilationFAERS: 1US FAERS
713Idiopathic Pulmonary FibrosisFAERS: 1US FAERS
714Immune thrombocytopenic purpuraFAERS: 1US FAERS
715Impaired gastric emptyingFAERS: 1US FAERS
716Impaired work abilityFAERS: 1US FAERS
717ImpatienceFAERS: 1US FAERS
718Incision site complicationFAERS: 1OFFSIDES
US FAERS
719Incorrect product storageFAERS: 1US FAERS
720Infectious peritonitisFAERS: 1US FAERS
721Infectious pleural effusionFAERS: 1US FAERS
722Intellectual DisabilityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
723Intentional drug misuseFAERS: 1US FAERS
724Intentional product misuseFAERS: 1US FAERS
725Intentional product use issueFAERS: 1US FAERS
726Intentional self-injuryFAERS: 1US FAERS
727Intercepted product dispensing errorFAERS: 1US FAERS
728Intervertebral disc compressionFAERS: 1US FAERS
729Intervertebral disc disorderFAERS: 1US FAERS
730Iron deficiencyFAERS: 1US FAERS
731Irregular sleep wake rhythm disorderFAERS: 1US FAERS
732Irritable Bowel SyndromeFAERS: 1US FAERS
733Itching scarFAERS: 1US FAERS
734KetoacidosisFAERS: 1US FAERS
735LaparotomyFAERS: 1US FAERS
736Large intestine perforationFAERS: 1US FAERS
737LaryngospasmFAERS: 1OFFSIDES
US FAERS
738LazinessFAERS: 1US FAERS
739Left Ventricular HypertrophyFAERS: 1US FAERS
740Lichen PlanusFAERS: 1US FAERS
741Lip erosionFAERS: 1US FAERS
742Local reactionFAERS: 1US FAERS
743Lower respiratory tract infection bacterialFAERS: 1US FAERS
744Lung infection pseudomonalFAERS: 1US FAERS
745Lung perforationFAERS: 1US FAERS
746Lymphocyte percentage decreasedFAERS: 1US FAERS
747Lymphocytic infiltrationFAERS: 1US FAERS
748Malignant HypertensionFAERS: 1US FAERS
749Mallory-Weiss SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
750Medication residue presentFAERS: 1US FAERS
751MegacolonFAERS: 1US FAERS
752Mental FatigueFAERS: 1US FAERS
753MicrocephalyFAERS: 1US FAERS
754Mixed dementiaFAERS: 1US FAERS
755Morganella infectionFAERS: 1US FAERS
756Motion SicknessFAERS: 1US FAERS
757Multiple sclerosis relapseFAERS: 1US FAERS
758Muscle CrampFAERS: 1US FAERS
759MutismFAERS: 1US FAERS
760Myasthenia GravisFAERS: 1US FAERS
761Myasthenic SyndromeFAERS: 1US FAERS
762Myocardial necrosis marker increasedFAERS: 1US FAERS
763Myocardial ruptureFAERS: 1US FAERS
764MyocarditisFAERS: 1US FAERS
765Myoglobin blood increasedFAERS: 1US FAERS
766Near DrowningFAERS: 1US FAERS
767NecrosisFAERS: 1US FAERS
768NephritisFAERS: 1US FAERS
769Neurological examination abnormalFAERS: 1US FAERS
770NeurosyphilisFAERS: 1US FAERS
771NeutropeniaFAERS: 1US FAERS
772NocturiaFAERS: 1OFFSIDES
SIDER
US FAERS
773Noninfective encephalitisFAERS: 1US FAERS
774Nuchal RigidityFAERS: 1US FAERS
775Occult blood positiveFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
776Oral dischargeFAERS: 1OFFSIDES
US FAERS
777Oral infectionFAERS: 1US FAERS
778Oral mucosal exfoliationFAERS: 1US FAERS
779OsteolysisFAERS: 1US FAERS
780OsteomyelitisFAERS: 1US FAERS
781OverweightFAERS: 1US FAERS
782Pacemaker complicationFAERS: 1US FAERS
783Packaging design issueFAERS: 1US FAERS
784Pancreatic NeoplasmFAERS: 1US FAERS
785PancytopeniaFAERS: 1US FAERS
786PapuleFAERS: 1US FAERS
787Paradoxical drug reactionFAERS: 1US FAERS
788Paranoid Personality DisorderFAERS: 1US FAERS
789Parkinsonian crisisFAERS: 1US FAERS
790Patient-device incompatibilityFAERS: 1US FAERS
791Pelvic PainFAERS: 1US FAERS
792PericarditisFAERS: 1US FAERS
793Peripheral arterial occlusive diseaseFAERS: 1US FAERS
794Peripheral paralysisFAERS: 1US FAERS
795PertussisFAERS: 1US FAERS
796Phantom painFAERS: 1US FAERS
797Physical assaultFAERS: 1US FAERS
798PiloerectionFAERS: 1US FAERS
799Post-Traumatic Stress DisorderFAERS: 1US FAERS
800Precancerous skin lesionFAERS: 1US FAERS
801Product availability issueFAERS: 1US FAERS
802Product design issueFAERS: 1US FAERS
803Product dispensing errorFAERS: 1US FAERS
804Product dose omissionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
805Product label counterfeitFAERS: 1US FAERS
806Product lot number issueFAERS: 1US FAERS
807Product physical issueFAERS: 1US FAERS
808Product supply issueFAERS: 1US FAERS
809Prolapse repairFAERS: 1US FAERS
810ProsopagnosiaFAERS: 1US FAERS
811Prosthesis ImplantationFAERS: 1OFFSIDES
US FAERS
812PrurigoFAERS: 1US FAERS
813PsoriasisFAERS: 1US FAERS
814Psychiatric decompensationFAERS: 1US FAERS
815Psychiatric evaluation abnormalFAERS: 1US FAERS
816Psychotic symptomFAERS: 1US FAERS
817Pulmonary HypertensionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
818Pulmonary arterial pressure increasedFAERS: 1OFFSIDES
US FAERS
819PyometraFAERS: 1US FAERS
820QuadriplegiaFAERS: 1US FAERS
821Rebound effectFAERS: 1US FAERS
822Refractory cytopenia with unilineage dysplasiaFAERS: 1US FAERS
823RegurgitationFAERS: 1US FAERS
824Renal cystFAERS: 1SIDER
US FAERS
825Renal painFAERS: 1US FAERS
826Renal tubular disorderFAERS: 1US FAERS
827Renal tubular necrosisFAERS: 1OFFSIDES
US FAERS
828Residual urine volumeFAERS: 1US FAERS
829Respiratory fume inhalation disorderFAERS: 1US FAERS
830Retrograde amnesiaFAERS: 1US FAERS
831RhabdomyolysisFAERS: 1US FAERS
832Rheumatoid ArthritisFAERS: 1SIDER
US FAERS
833Rubber sensitivityFAERS: 1US FAERS
834Ruptured cerebral aneurysmFAERS: 1US FAERS
835SclerodermaFAERS: 1OFFSIDES
US FAERS
836Secretion dischargeFAERS: 1US FAERS
837Sense of oppressionFAERS: 1US FAERS
838Serotonin SyndromeFAERS: 1US FAERS
839Sinoatrial BlockFAERS: 1US FAERS
840Sjogren's SyndromeFAERS: 1US FAERS
841Skin ErosionFAERS: 1US FAERS
842Skin PapillomaFAERS: 1SIDER
US FAERS
843Slow response to stimuliFAERS: 1US FAERS
844SoliloquyFAERS: 1US FAERS
845SoporFAERS: 1OFFSIDES
US FAERS
846Splenic RuptureFAERS: 1US FAERS
847Splenic neoplasm malignancy unspecifiedFAERS: 1US FAERS
848SplenomegalyFAERS: 1US FAERS
849Sputum retentionFAERS: 1US FAERS
850StaringFAERS: 1US FAERS
851StarvationFAERS: 1US FAERS
852StomatitisFAERS: 1US FAERS
853Subcutaneous EmphysemaFAERS: 1US FAERS
854Sudden Cardiac DeathFAERS: 1SIDER
US FAERS
855Superficial vein prominenceFAERS: 1US FAERS
856Supraventricular tachycardiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
857Synovial CystFAERS: 1US FAERS
858TachyarrhythmiaFAERS: 1US FAERS
859TaciturnityFAERS: 1US FAERS
860Temperature intoleranceFAERS: 1US FAERS
861Temperature regulation disorderFAERS: 1US FAERS
862Temporal ArteritisFAERS: 1US FAERS
863Therapy non-responderFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
864Therapy regimen changedFAERS: 1US FAERS
865Thermal burnFAERS: 1US FAERS
866Thromboangiitis ObliteransFAERS: 1US FAERS
867Thrombotic cerebral infarctionFAERS: 1US FAERS
868Tinea PedisFAERS: 1US FAERS
869Tongue movement disturbanceFAERS: 1US FAERS
870Tooth InfectionFAERS: 1US FAERS
871TorticollisFAERS: 1US FAERS
872Traumatic Brain InjuryFAERS: 1US FAERS
873TrismusFAERS: 1US FAERS
874Tympanic Membrane PerforationFAERS: 1US FAERS
875UreterolithiasisFAERS: 1US FAERS
876Urethral ObstructionFAERS: 1US FAERS
877Urge IncontinenceFAERS: 1US FAERS
878Urinary bladder polypFAERS: 1US FAERS
879Urinary sediment presentFAERS: 1US FAERS
880Uterine PolypFAERS: 1US FAERS
881Vaginal DischargeFAERS: 1US FAERS
882Varicose vein operationFAERS: 1US FAERS
883Vascular fragilityFAERS: 1US FAERS
884Vascular insufficiencyFAERS: 1US FAERS
885Vascular occlusionFAERS: 1US FAERS
886Vascular ruptureFAERS: 1US FAERS
887VasculitisFAERS: 1SIDER
US FAERS
888Venous InjuryFAERS: 1US FAERS
889Venous thrombosis limbFAERS: 1US FAERS
890Ventricular arrhythmiaFAERS: 1US FAERS
891Vertebral wedgingFAERS: 1US FAERS
892Vertebrobasilar InsufficiencyFAERS: 1US FAERS
893Viral upper respiratory tract infectionFAERS: 1US FAERS
894Visual disturbanceFAERS: 1US FAERS
895Walking aid userFAERS: 1US FAERS
896Wheelchair userFAERS: 1OFFSIDES
US FAERS
897White blood cell count abnormalFAERS: 1US FAERS
898Whole blood transfusionFAERS: 1US FAERS
899Wound InfectionFAERS: 1OFFSIDES
US FAERS
900Wrong patient received medicationFAERS: 1US FAERS
901kyphosisFAERS: 1US FAERS
902skin abrasionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
903Abnormal visionSIDER
904Acute Coronary SyndromeSIDER
905Adams-Stokes SyndromeSIDER
906Adrenal massOFFSIDES
907Aggressive reactionSIDER
908AgraphiaOFFSIDES
909AlbuminuriaSIDER
910Anal sphincter atonyOFFSIDES
911AngioplastyOFFSIDES
912Anorectal discomfortSIDER
913Application site eczemaSIDER
914Application site fissureCanada Vigilance: 1Canada Vigilance
915Arterial bruitOFFSIDES
916Artificial crown procedureOFFSIDES
917Aspartate aminotransferase decreasedOFFSIDES
918AsterixisOFFSIDES
919Asthenic conditionsSIDER
920Atrial FlutterOFFSIDES
921Atrioventricular extrasystolesOFFSIDES
922Atrophic vulvovaginitisSIDER
923AuraOFFSIDES
924AutomatismOFFSIDES
925Basal Ganglia Diseases17972045CTD
926BicytopeniaOFFSIDES
927Bladder discomfortCanada Vigilance: 1Canada Vigilance
928Bladder neck obstructionOFFSIDES
929Bladder painSIDER
930BlepharitisSIDER
931Blood amylase decreasedOFFSIDES
932Blood and lymphatic system disordersSIDER
933Blood prolactin increasedSIDER
934Blood triglycerides increasedCanada Vigilance: 1Canada Vigilance
935BradykinesiaSIDER
936Bronchial HyperreactivitySIDER
937Bullous eruptionSIDER
938Candidiasis of vaginaOFFSIDES
939CandiduriaOFFSIDES
940CarcinomaSIDER
941Carpal Tunnel SyndromeCanada Vigilance: 1Canada Vigilance
942Chemical and Drug Induced Liver Injury19888250CTD
943Chronic Fatigue SyndromeOFFSIDES
944ClonusOFFSIDES
945Coagulation factor V level decreasedOFFSIDES
946Cognition Disorders14638981
15630600
17652827
CTD
947Cogwheel RigiditySIDER
948Common wartSIDER
949Compulsive sexual behaviourOFFSIDES
950ConfabulationOFFSIDES
951ConjunctivitisSIDER
952Contact DermatitisOFFSIDES
953Cramps of lower extremitiesSIDER
954Cutaneous hypersensitivitySIDER
955Cytomegalovirus antibody positiveOFFSIDES
956Delusional perceptionOFFSIDES
957DiarrheaOFFSIDES
958Disturbance in sexual arousalSIDER
959DrowsinessSIDER
960Drug use for unknown indicationOFFSIDES
961Ear and labyrinth disordersSIDER
962Electrocardiogram QT corrected intervalOFFSIDES
963Embolic strokeOFFSIDES
964Endometrial HyperplasiaOFFSIDES
965Endometrial hypertrophySIDER
966Eosinophilic PneumoniaOFFSIDES
967Erectile dysfunctionSIDER
968Eye InfectionCanada Vigilance: 1Canada Vigilance
969Eye painSIDER
970Fever18294120CTD
971Flat affectSIDER
972FurunculosisSIDER
973Gastric adenomaOFFSIDES
974Gastric hypermotilityOFFSIDES
975Gastrointestinal hypermotilityOFFSIDES
976Gastrointestinal obstructionOFFSIDES
977Genital erythemaOFFSIDES
978GingivitisSIDER
979GlossitisSIDER
980Growth of eyelashesOFFSIDES
981Heart sounds abnormalSIDER
982Hepatitis A positiveOFFSIDES
983Hepatitis AOFFSIDES
984HyperkeratosisSIDER
985Iatrogenic injuryOFFSIDES
986Increased prolactin levelSIDER
987InfestationSIDER
988Influenza-like symptomsSIDER
989Infusion site reactionOFFSIDES
990Injection site inflammationOFFSIDES
991Injury asphyxiationOFFSIDES
992Lacrimation abnormal NOSSIDER
993Lactose IntoleranceOFFSIDES
994Large intestine anastomosisOFFSIDES
995LaryngitisSIDER
996Living in residential institutionCanada Vigilance: 2Canada Vigilance
997Loose toothOFFSIDES
998Loss of personal independence in daily activitiesCanada Vigilance: 1Canada Vigilance
999LymphadenopathySIDER
1000Magnesium DeficiencyOFFSIDES
1001MastectomyOFFSIDES
1002MastitisSIDER
1003Memory Disorders19005644
20523872
CTD
1004MetrorrhagiaSIDER
1005Mononucleosis syndromeOFFSIDES
1006Motor retardationOFFSIDES
1007Nervous tensionOFFSIDES
1008NeuralgiaSIDER
1009Neurological eyelid disorderOFFSIDES
1010NeuropathySIDER
1011NystagmusSIDER
1012Oncologic complicationOFFSIDES
1013OnychomycosisSIDER
1014Oral mucosal erythemaOFFSIDES
1015Otitis ExternaSIDER
1016Otitis MediaSIDER
1017Pain managementOFFSIDES
1018Palliative CareOFFSIDES
1019Paranoid reactionSIDER
1020Parkinson Disease16941467CTD
1021Parkinsonian Disorders17972045CTD
1022PneumocephalusOFFSIDES
1023PolyuriaSIDER
1024Portal hypertensive gastropathyOFFSIDES
1025PostmenopauseOFFSIDES
1026Product complaintCanada Vigilance: 1Canada Vigilance
1027Product contaminationOFFSIDES
1028Prostatic AdenomaSIDER
1029Prostatic ObstructionOFFSIDES
1030Prothrombin level decreasedOFFSIDES
1031Prothrombin time ratio decreasedOFFSIDES
1032PseudodementiaCanada Vigilance: 1Canada Vigilance
1033Psychotic Disorders14638981CTD
1034PyuriaSIDER
1035Rectal ObstructionOFFSIDES
1036Rectal tenesmusSIDER
1037Renal ColicCanada Vigilance: 1Canada Vigilance
OFFSIDES
1038Respiratory InsufficiencySIDER
1039Restless Legs SyndromeSIDER
1040Retrosternal painSIDER
1041RhinitisSIDER
1042Scrotal irritationOFFSIDES
1043SigmoiditisOFFSIDES
1044Skin cold clammySIDER
1045Skin lacerationCanada Vigilance: 1Canada Vigilance
1046Soft tissue inflammationOFFSIDES
1047SpondylitisOFFSIDES
1048StiffnessSIDER
1049Stomach acheSIDER
1050SubileusOFFSIDES
1051Substance-Related Disorders20393457CTD
1052SunburnSIDER
1053SweatingSIDER
1054TensionSIDER
1055Thoracic cavity drainageOFFSIDES
1056TraumaSIDER
1057TremblingSIDER
1058Troponin increasedOFFSIDES
1059Ulcerative stomatitisSIDER
1060UnwellSIDER
1061Urine output increasedSIDER
1062Uterine CancerCanada Vigilance: 1Canada Vigilance
1063Vascular purpuraSIDER
1064Vena cava filter insertionOFFSIDES
1065Venous InsufficiencyOFFSIDES
1066Vitamin B 12 DeficiencyOFFSIDES
1067colonoscopyOFFSIDES
1068furuncleSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.